ロード中...
Metformin and Prostate Cancer: Benefit for Development of Castration-resistant Disease and Prostate Cancer Mortality
BACKGROUND: In vitro data and early clinical results suggest that metformin has desirable antineoplastic effects and has a theoretical benefit on castration-resistant prostate cancer (CRPC). OBJECTIVE: To determine whether the use of metformin would be associated with improved clinical outcomes and...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4034673/ https://ncbi.nlm.nih.gov/pubmed/23287698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2012.12.004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|